Abstract
Halting vaccine-derived poliovirus circulation: the novel type 2 oral vaccine might not be enough
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s2214-109x(23)00161-4
Copy DOIJournal: The Lancet Global Health | Publication Date: May 16, 2023 |
Citations: 4 | License type: cc-by-nc-nd |
Halting vaccine-derived poliovirus circulation: the novel type 2 oral vaccine might not be enough
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.